Még nem toboroz
A Study Evaluating Safety and Tolerability of Switching From Semaglutide to Zovaglutide in Adults With Obesity (HORIZON-SWITCH-SZ)
NCT07812597· 2. fázis· Beijing QL Biopharmaceutical Co.,Ltd· Forrás
Toboroz
A Study of ATG-022 Compared With Investigator's Choice of Treatment in Claudin 18.2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
NCT07795346· 3. fázis· Antengene Biologics Limited· Forrás
Toboroz
Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL-2)
NCT07800572· 2. fázis· Capital Medical University· Forrás
Még nem toboroz
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Systemic Lupus Erythematosus
NCT07760155· 2. fázis· Shanghai Escugen Biotechnology Co., Ltd· Forrás
Toboroz
Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
NCT07796516· 2. fázis· Peking University People's Hospital· Forrás
Toboroz
The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome (TS) and Short Stature
NCT07614152· 3. fázis· Xiamen Amoytop Biotech Co., Ltd.· Forrás
Toboroz
Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System
NCT07745244· SiBionics, Co, Ltd· Forrás
Fut, nem toboroz
Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL)
NCT07513233· 1. fázis· Capital Medical University· Forrás
Toboroz
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion Stroke
NCT07509645· 3. fázis· Capital Medical University· Forrás
Toboroz
Phase II Trial of RC1416 Injection in Asthma
NCT07403487· 2. fázis· Nanjing RegeneCore Biotech Co., Ltd.· Forrás
Még nem toboroz
A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE)
NCT07274137· 3. fázis· MindRank AI Ltd· Forrás
Fut, nem toboroz
A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)
NCT07230119· 3. fázis· Beijing QL Biopharmaceutical Co.,Ltd· Forrás
Fut, nem toboroz
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2
NCT07263776· 3. fázis· Capital Medical University· Forrás
Fut, nem toboroz
Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
NCT07107256· 3. fázis· Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.· Forrás
Toboroz
ICP-332 in Subjects With Non-segmental Vitiligo
NCT07047612· 2/3. fázis· Beijing InnoCare Pharma Tech Co., Ltd.· Forrás
Toboroz
Clinical Study on the Treatment of Type 1 Diabetes With CNK-UT009 Cell Injection
NCT07051564· Zibo Central Hospital· Forrás
Toboroz
Phase II Trial of Iparomlimab/Tuvonralimab (QL1706) + XELOX in HER2-Negative, Low PD-L1 G/GEJ Adenocarcinoma
NCT06932068· 2. fázis· Qilu Hospital of Shandong University· Forrás
Toboroz
TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
NCT06829784· 3. fázis· Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.· Forrás
Toboroz
Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
NCT06548971· 3. fázis· Capital Medical University· Forrás
Még nem toboroz
The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).
NCT06606509· Nanjing First Hospital, Nanjing Medical University· Forrás
Toboroz
First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)
NCT06730373· 2. fázis· Qilu Hospital of Shandong University· Forrás
Toboroz
A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology
NCT06662071· Qilu Hospital of Shandong University· Forrás
Fut, nem toboroz
SIM0718 Treatment of Asthma Clinical Study
NCT06488755· 3. fázis· Simcere Pharmaceutical Co., Ltd· Forrás
Toboroz
Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
NCT07169656· The First Affiliated Hospital of Zhengzhou University· Forrás
Toboroz
Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
NCT05866029· Peking Union Medical College Hospital· Forrás
Toboroz
Post-market European & Asian Registry to Evaluate the Minos™ Stent-Graft and Delivery System in Abdominal Aortic Aneurysm Treatment
NCT07674173· Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd· Forrás
Fut, nem toboroz
A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease
NCT06295679· Amgen· Forrás
Fut, nem toboroz
To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer
NCT05365178· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Toboroz
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
NCT05150691· 1/2. fázis· DualityBio Inc.· Forrás
Még nem toboroz
Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
NCT04995159· Lepu Medical Technology (Beijing) Co., Ltd.· Forrás